OnLume Inc. news

Ten companies and nonprofit organizations have been selected as finalists for the 2020 Wisconsin Innovation Awards. In total, over 380 businesses, products and services from around the state were nominated. The finalists were determined by a panel of 30 statewide industry experts, with winners to be announced on October 13, 2020 at a virtual awards ceremony. Nominations spanned all parts of Wisconsin, representing large, medium and small companies, startups, established businesses, and nearly

Last night, four winners were honored from ten finalists and almost 400 nominees during the 2020 Wisconsin Innovation Awards which was broadcast live from Milwaukee. The ceremony, emceed by Wisconsin local Denise Thomas, President at The Effective Communication Coach, LLC, recognized the state’s most innovative products and services. The 2020 winners were selected by a panel of 30 expert judges with backgrounds in many business sectors – technology, food, healthcare, agriculture,

OnLume Surgical, a Wisconsin-based medical device company developing novel imaging systems for use during surgery, announced the completion of its Series A funding to assist its plans for commercial launch.  

OnLume raised over $7 Million in this financing, adding to a $2 Million Phase II SBIR grant from the National Cancer Institute (NCI) of the National Institutes of Health (NIH), awarded in late 2020.

“The completion of the Series A financing, plus the Phase II g

OnLume Inc., a Madison, Wisconsin-based medical imaging company with unique technology for improving surgical precision in the operating room, has announced the start of participation in a clinical trial combining its fluorescence-guided surgery (FGS) imaging device with a novel nerve-targeting agent.

OnLume has unique FGS imaging technology to illuminate critical anatomy in real time during surgery to optimize surgical precision, which can lead to improved patient outcomes, reduced m

OnLume has received 510(k) clearance from the U.S. Food & Drug Administration (“FDA”) to market its first product, a fluorescence guided surgery (FGS) system.

The OnLume Imaging System is indicated for fluorescence imaging of blood flow and tissue perfusion before, during, and after vascular, gastrointestinal, organ transplant, plastic, reconstructive, and micro surgeries. This intraoperative imaging technology is used in conjunction with the FDA approved indocyanine g